Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Marti Announces Commencement of an Offer to Purchase and Consent Solicitation Relating to its Warrants
-
Cantor Fitzgerald Downgrades Mainz Biomed B.V. (MYNZ) to Neutral
-
Sprott Physical Uranium Trust Announces Updated “At-the-Market” Equity Program
-
Caledonia Mining Corporation Plc: Utilisation of the block admission in respect of ATM Sales Agreement
-
Form 424B3 Cantor Fitzgerald Income
-
Hefty options 'disaster hedges' draw buyers as US stocks extend rally
-
Fannie Mae Prices $609 Million Connecticut Avenue Securities (CAS) REMIC Deal
-
Form N-23C3A CANTOR FITZGERALD INFRAS For: Nov 17
-
Mainz Biomed (MYNZ) Reports Q3 Results
-
Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
Orchid Island Capital Announces November 2023 Monthly Dividend and October 31, 2023 RMBS Portfolio Characteristics
-
Cantor Fitzgerald Downgrades Bristol-Myers Squibb Co. (BMY) to Neutral, 'Getting Out of This Value Trap'
-
Form 13F-NT Cantor Fitzgerald Europe For: Sep 30
-
Form 13F-NT CANTOR FITZGERALD SECURI For: Sep 30
-
Form 13F-HR CANTOR FITZGERALD, L. For: Sep 30
-
Form 13F-NT CANTOR FITZGERALD INVEST For: Sep 30
-
Form 13F-NT CANTOR FITZGERALD & CO. For: Sep 30
-
View Announces Q3 2023 Earnings
-
Lucid Diagnostics Inc (LUCD) PT Lowered to $3.80 at Cantor Fitzgerald
-
Alaunos Therapeutics (TCRT) Reports Q3, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
-
Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
-
Form 10-Q Cantor Fitzgerald Income For: Sep 30
-
Cantor Fitzgerald cuts 2U (TWOU) to Neutral as tech firm faces debt maturity
-
LifeMD to Participate in Upcoming Investor Conferences and Panel Discussions
-
Cantor Fitzgerald Starts NeuroPace Inc (NPCE) at Overweight, 'Wired for Success'
-
Cantor Fitzgerald Downgrades 2U, Inc. (TWOU) to Neutral
-
Investors spurn options hedges as U.S. stock rally crushes fear
-
Cantor Fitzgerald cuts Lucid (LCID) to Neutral following 3Q revenue miss
-
Cantor Fitzgerald Downgrades Lucid Group Inc. (LCID) to Neutral, 'lower expected revenues'
-
Point and Redwood Trust Issue $139 Million Home Equity Investment Rated Securitization
-
Fortinet (FTNT) plunges 23% on lowered full-year guidance; Prompts several downgrades
-
Form 8-K Cantor Fitzgerald Income For: Nov 02
-
Cantor Fitzgerald and Harbor Group International Expand Relationship with Joint Venture to Acquire Westchester Multifamily Community
-
Cantor Fitzgerald Starts VinFast Auto Ltd. (VFS) at Overweight, 'good entry-point'
-
Theratechnologies Announces Closing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement
-
Cantor Fitzgerald Upgrades Pacific Biosciences of California (PACB) to Overweight, 'attractive entry point'
-
Sarepta Therapeutics crushed after EMBARK misses primary endpoint, prompting 2 downgrades
-
DIF Capital Partners and EDF Invest to acquire leading Norwegian electric ferry operator Fjord1 from Vision Ridge Partners and Havila Holding
-
Zynex (ZYXI) Initiates Review of Strategic Alternatives
-
Zynex Announces Review of Strategic Alternatives
-
Cantor Fitzgerald upgrades Rivian (RIVN) to Overweight following recent pullback
-
Maverick Natural Resources closes $640 million asset-backed securitization
-
After-hours stock movers: Intel jumps on beat, Enphase siks
-
Cantor Fitzgerald Upgrades Rivian Automotive Inc (RIVN) to Overweight, 'We Expect Strong Demand to Continue into 2024'
-
Orchid Island Capital Announces Third Quarter 2023 Results
-
Theratechnologies (THTX) Prices $25M Share Offering at $1/sh
-
Theratechnologies Announces Pricing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement
-
Theratechnologies (THTX) Announces Proposed Public Offering of Common Shares and Concurrent Private Placement
-
Theratechnologies Announces Proposed Public Offering of Common Shares and Concurrent Private Placement
-
Form 424B3 Cantor Fitzgerald Income

